VistaGen Therapeutics, Inc. ( VTGN) - Stock Earnings
VTGN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
VTGN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -19.4 million USD | 258000 USD |
| 2025Q4 | -18.9 million USD | 303000 USD |
| 2026Q1 | -16.3 million USD | 465000 USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
VTGN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -29.4 million USD | 1.1 million USD |
| 2025 | -51.4 million USD | 486000 USD |
| 2026 | -69.7 million USD | 1.3 million USD |
| 2026 Est. | — | — |
VTGN
Price: $0.24
Earnings Per Share: -1.83 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 11.3 million
Ebitda: -2.8 millionMarket Capitalization: 10.1 million